OpenVSafe by OpenVAERS
Search V-safe

PVJ-72644-78734

2 vaccinations 1 coded response 1 check-in 0 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
458 / OH
Registered
2022-03-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-01-03
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-22
    Dose 2 — Pfizer-BioNTech
  3. 2022-03-20
    Registered in v-safe
  4. 2023-01-24
    Survey response — 12 months, dose 2
    MedDRA: Back pain, Basal cell carcinoma, Dizziness, Fatigue, Headache, Hypothyroidism, Insomnia, Malaise, Menstruation irregular, Nasopharyngitis, Nausea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  5. 2023-01-24
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  6. 2023-01-25
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12022-01-03Pfizer-BioNTech No
22022-01-22Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBack pain · · ✓
SDBasal cell carcinoma · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHypothyroidism · · ✓
SDInsomnia · · ✓
SDMalaise · · ✓
SDMenstruation irregular · · ✓
SDNasopharyngitis · · ✓
SDNausea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release